Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34407543

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Nov 25
First author
Cortes J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Nov 25;138(21):2011-2012. doi: 10.1182/blood.2021013284.
    note
    Source null
    related pmid
    34821935
    relationship
    Comment in

Authors and identifiers

  1. name
    Cortes J
    type
    Author
  2. name
    Apperley J
    type
    Author
  3. name
    Lomaia E
    type
    Author
  4. name
    Moiraghi B
    type
    Author
  5. name
    Undurraga Sutton M
    type
    Author
  6. name
    Pavlovsky C
    type
    Author
  7. name
    Chuah C
    type
    Author
  8. name
    Sacha T
    type
    Author
  9. name
    Lipton JH
    type
    Author
  10. name
    Schiffer CA
    type
    Author
  11. name
    McCloskey J
    type
    Author
  12. name
    Hochhaus A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cortes J
    type
    Author
  2. name
    Apperley J
    type
    Author
  3. name
    Lomaia E
    type
    Author
  4. name
    Moiraghi B
    type
    Author
  5. name
    Undurraga Sutton M
    type
    Author
  6. name
    Pavlovsky C
    type
    Author
  7. name
    Chuah C
    type
    Author
  8. name
    Sacha T
    type
    Author
  9. name
    Lipton JH
    type
    Author
  10. name
    Schiffer CA
    type
    Author
  11. name
    McCloskey J
    type
    Author
  12. name
    Hochhaus A
    type
    Author
bibliography ids
  1. nci-bib-c0e8e4be4f76f9a5afa0e63f
book metadata
content sha256
c413586698ed8dc0bf757d27f4e2e996e6b786245cb874512926481830afbfa2
document type
citation
dois
  1. 10.1182/blood.2021012082
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34407543
immutable id
pubmed:34407543@c413586698ed8dc0bf757d27f4e2e996e6b786245cb874512926481830afbfa2
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
21
name
Blood
nlm unique id
7603509
pages
2042-2050
volume
138
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Nov 25;138(21):2011-2012. doi: 10.1182/blood.2021013284.
    note
    Source null
    related pmid
    34821935
    relationship
    Comment in
outcomes validated
false
pmid
34407543
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
03fea704bf5ecaf2d338ab4a49ac9850d0c191e994a1aa2b4047d736545d8be4
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Nov 25
precision
day
year
2021
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34407543/
title
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.

Preserved source evidence · Not medical advice